Aristotle Boston reviews Q3 2025 performance, highlighting strategic buys and long-term value drivers. Explore how portfolio ...
CorMedix acquires Melinta, diversifies products, and raises 2025 revenue outlook to $375M. Read here for more details on CRMD ...
As the table shows, the best performer of the group has been Judges Scientific (JDG), shares in which had risen by over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback